Effects of Common Therapies for Threatened Preterm Labor on the Placental Inflammatory Response
American Journal of Reproductive Immunology · 2026-09 · 96 (3)
DOI: 10.1111/aji.70316 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, online erschienen am 31.08.2026. Verfasst von Jessica Weng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic Medical Scientist Training Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic Alix School of Medicine, Rochester, M…. Hauptthemen laut MEDLINE: Obstetric Labor, Premature, Placenta, Inflammation. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences (NIGMS).
Abstract (Originalsprache)
Problem Patients with threatened preterm labor (PTL) are treated with antibiotics, corticosteroids, and magnesium sulfate to mitigate infection, promote fetal lung maturation, provide fetal neuroprotection and overall minimize the impact of prematurity on the neonate. However, the effect of these drugs on the placental inflammatory profile is unknown even though these are given systemically and reach the placenta. We evaluated their action in an ex vivo model of placental inflammation. Method of Study Placental explants from uncomplicated pregnancies were exposed to lipopolysaccharide (LPS) ± azithromycin, betamethasone, and/or magnesium sulfate. Production (lysate) and secretion (supernatant) of pro‐ and anti‐inflammatory cytokines were assessed by ELISA.
Results
Both pro‐ and anti‐inflammatory cytokines were increased by LPS versus untreated. Azithromycin, or magnesium sulfate did not alter the inflammatory profile by themselves nor when added at the same time or 24 h after LPS. Betamethasone decreased both pro‐ and anti‐inflammatory cytokines only when administered at the same time as LPS, without any effects if delayed.
Conclusions
Therapeutic interventions classically used for preterm labor (PTL) do not impact the placental inflammatory profile by themselves or in the context of an ex vivo placental explants model of LPS‐induced inflammation, except for betamethasone when administered concurrently with LPS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mayo Clinic Medical Scientist Training Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic Alix School of Medicine, Rochester, Minnesota, USA.
- Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of OB-GYN, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Jessica Weng, Francisco Cortina, Suyun Ling, Sylvie Girard
Förderung
- NICHD NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences (NIGMS)
- National Institute of Child Health and Development (NICHD)
- Mayo Clinic
Zitieren
APA
Weng, J., Cortina, F., Ling, S., & Girard, S. (2026). Effects of Common Therapies for Threatened Preterm Labor on the Placental Inflammatory Response. American Journal of Reproductive Immunology, 96(3). https://doi.org/10.1111/aji.70316
Vancouver
Weng J, Cortina F, Ling S, Girard S. Effects of Common Therapies for Threatened Preterm Labor on the Placental Inflammatory Response. American Journal of Reproductive Immunology. 2026;96(3). doi:10.1111/aji.70316
BibTeX
@article{Weng2026,
author = {Weng, Jessica and Cortina, Francisco and Ling, Suyun and Girard, Sylvie},
title = {Effects of Common Therapies for Threatened Preterm Labor on the Placental Inflammatory Response},
journal = {American Journal of Reproductive Immunology},
year = {2026},
volume = {96},
number = {3},
doi = {10.1111/aji.70316}
}
EUVIMED